drugset / Trial / NCT01235871

A Single and Multiple-Dose Study of SB1578

NCT01235871 ↗

Phase 1 Completed 40 enrolled S*BIO
RandomizedParallel-groupTriple-blindBasic science

Summary

The purpose of this study is to determine the safety, tolerability, pharmacokinetics and pharmacodynamics of SB1578 in healthy volunteers.

Timeline

Start
2010-08
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject CT-1578 Small molecule — Oral

Indications

No indication recorded.